GA-II: Began Phase I trials

Transkaryotic Therapies Inc. (TKTX), Cambridge, Mass. Product: GA-II Business: Gene/Cell therapy Therapeutic category: Gene therapy Target: Undisclosed Description: Gene activated protein product Indi...